Aura Biosciences (AURA) vs MiMedx Group (MDXG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aura Biosciences (AURA) has outperformed MiMedx Group (MDXG) over the past year, gaining 6.8% versus a loss of 34.9%. Aura Biosciences is the larger company by market cap ($674.6 million vs $674.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AURA | MDXG |
|---|---|---|
| Share price | $6.51 | $4.62 |
| Market cap | $674.60M | $674.22M |
| 1-day change | +0.70% | +0.22% |
| YTD return | +19.36% | -31.76% |
| 1-year return | +6.81% | -34.93% |
| 5-year return | — | -31.66% |
| P/E ratio (TTM) | — | 115.50 |
| Forward P/E | — | 23.10 |
| EPS (TTM) | $-1.75 | $0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.54 | $7.97 |
| 52-week low | $4.73 | $3.03 |
| Distance from 52-week high | -31.78% | -42.03% |
| Analyst consensus | none | none |
| Avg. price target upside | +155.19% | +60.17% |
| Average volume | 740.43K | 1.23M |
| Shares outstanding | 103.70M | 145.93M |
| Employees | 113 | 808 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AURA has outperformed MDXG by 41.7 percentage points over the past year.
About Aura Biosciences
AURA stock →Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 113 employees
About MiMedx Group
MDXG stock →MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.
Health Care · Medical/Dental Instruments · 808 employees
AURA vs MDXG FAQ
Which is bigger, Aura Biosciences or MiMedx Group?
Aura Biosciences (AURA) is larger, with a market capitalization of $674.60M compared with $674.22M for MiMedx Group (MDXG).
Which stock has performed better over the past year, AURA or MDXG?
AURA returned +6.81% over the past 12 months, compared with -34.93% for MDXG (price return, excluding dividends). Past performance does not predict future results.
Are Aura Biosciences and MiMedx Group in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Aura Biosciences and Medical/Dental Instruments for MiMedx Group.